NASA’s Noise-Testing Tool Finds Applications Beyond Aircrafts
Airplane manufacturers running noise tests on new aircraft now have a much cheaper option than traditional wired microphone arrays. And it’s sensitive enough to help farmers with pest problems. The wireless microphone array that one company recently created with help from NASA can locate crop-threatening insects by listening for sounds they make in fields. And now, it’s making fast, affordable testing possible almost anywhere.
Beacon Therapeutics Raises $170 Million in Series B Funding to Advance Development of Ophthalmic Gene Therapies
Beacon Therapeutics, a leading ophthalmic gene therapy company that acquired UF startup AGTC to save and restore the vision of patients with blinding retinal diseases, announced it has raised $170 million in Series B funding.
American Dream: Taiwan-Born UF Professor Wins Prestigious NASA Award
Esteemed UF professor Jacob Chung was awarded NASA's Exceptional Public Service Medal in late June. The award is among the highest honors bestowed by the NASA.
Underwater Data Centers
Cybersecurity and robotics researchers at the UF College of Engineering discovered that the inherent density of water can turn sound into a potential weapon to underwater data centers.
Tech Tuesday: How Entrepreneurship and Innovation Can Expand Research
In this week’s Tech Tuesday, host Bethany Gaffey introduces us to UF's May Khanna, a researcher who's driving entrepreneurship and innovation. Research drives entrepreneurship, and entrepreneurship expands research.
Oragenics Develops Automated Intranasal Device for Treating Concussed Patients
Oragenics, Inc., a UF Innovate | Accelerate alumnus company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, announced it has completed a prototype of its automated intranasal device for use in concussed patients who are initially confused, dazed or unconscious in the acute phase of injury.
Solid Biosciences Joins the Russell 3000® Index
Solid Biosciences Inc., a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases that acquired UF startup AavantiBio, announced it has been added to the broad-market Russell 3000® Index as part of the annual reconstitution, effective July 1st, 2024.
Florida’s Startup Surge: Insights from UF Innovate Ventures w/ Dr. Jackson Streeter
7 in 7 with Zach Ellison Episode #12A of Season 2 features Dr. Jackson Streeter, director of UF Innovate | Ventures at the University of Florida, where he manages a venture fund for the University of Florida Research Foundation.
Tambellini Group Awards University of Florida Grand Prize for Inaugural Future Campus Award
The University of Florida has been awarded the grand prize in the Tambellini Group’s inaugural Future Campus Award, recognizing UF's pioneering work in integrating AI across its curriculum. The award was presented at Tambellini's Future Campus Summit in New York City.
MBI Researchers to Test Novel Treatments for Medulloblastoma
University of Florida researchers have received approval from the Food and Drug Administration to test two new experimental therapies in first-ever human clinical trials for a subtype of medulloblastoma, the most common pediatric malignant brain tumor.
